youtube_live
Q3 2026 earnings • released • EPS beat +2.67% • Revenue miss -2.92%
See resultschevron_right
COO:NASDAQ
Cooper Companies Inc
$54.17
arrow_downward
-14.67%(-9.31) 1D
$54.50
arrow_upward
+0.61% (+0.33)bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COO...
Open
$51.88
High
$55.43
Low
$51.01
Mkt. cap
10.56B
Avg. vol.
2.03M
Volume
18.65M
P/E ratio
45.76
52-wk high
$89.83
52-wk low
$51.01
EPS
$1.18
Beta
0.82
Shares outstanding
195.03M
No. of employees
15K
Open
$51.88
High
$55.43
Low
$51.01
Mkt. cap
10.56B
Avg. vol.
2.03M
Volume
18.65M
P/E ratio
45.76
52-wk high
$89.83
52-wk low
$51.01
EPS
$1.18
Beta
0.82
Shares outstanding
195.03M
No. of employees
15K
News stories
From web sources and news partners
Yahoo Finance
·
6 hours ago
Why is CooperCompanies Stock Down 15% Today?
Benzinga
·
6 hours ago
Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High
News Corp
·
6 hours ago
Barron’s Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap
Barron's
·
6 hours ago
Barron’s Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap
Profile
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market. Wikipedia
About Cooper Companies Inc
CEOAlbert G. White III
Employees15K
Founded1958
HeadquartersPleasanton, California, United States
SectorMedical device
Websitecoopercos.com
Analyst ratings
Based on 12 analysts giving stock ratings to COO in the past 3 months
Hold
Buy
3
Hold
9
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for COO in the last 3 months.
Highest
Current $54.17
$73.00 (+34.76%)
Average
$64.30 (+18.70%)
Lowest
$58.00 (+7.07%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Young Li Jefferies | Buy | Maintained | $70.00 | +29.2% | 09/10/2026 |
Steven Lichtman William Blair | Hold | Downgraded | - | - | 09/10/2026 |
Patrick Wood UBS | Hold | Reiterated | $66.00 | +21.8% | 09/10/2026 |
Robbie Marcus J.P. Morgan | Hold | Reiterated | $58.00 | +7.1% | 09/10/2026 |
Joanne Wuensch Citi | Hold | Maintained | $60.00 | +10.8% | 09/10/2026 |
Jonathan Block Stifel Nicolaus | Buy | Maintained | $70.00 | +29.2% | 09/10/2026 |
David Saxon Needham | Buy | Maintained | $73.00 | +34.8% | 09/10/2026 |
Travis Steed Bank of America Securities | Hold | Downgraded | $65.00 | +20% | 09/10/2026 |
Larry Biegelsen Wells Fargo | Hold | Maintained | $61.00 | +12.6% | 09/09/2026 |
Jason Bednar Piper Sandler | Hold | Downgraded | $59.00 | +8.9% | 09/10/2026 |
Jeff Johnson Robert W. Baird | Hold | Downgraded | $61.00 | +12.6% | 09/10/2026 |
Brett Fishbin KeyBanc | Hold | Maintained | - | - | 09/10/2026 |
Unknown Analyst UBS | Hold | Initiated | $75.00 | +38.5% | 07/28/2026 |
Anthony Petrone Mizuho Securities | Buy | Maintained | $85.00 | +56.9% | 06/03/2026 |
David Roman Goldman Sachs | Sell | Maintained | $61.00 | +12.6% | 05/27/2026 |
Unknown Analyst Wells Fargo | Hold | Reiterated | $82.00 | +51.4% | 05/22/2026 |
Matt Miksic Barclays | Buy | Reiterated | $103.00 | +90.1% | 03/24/2026 |
Issie Kirby Rothschild & Co Redburn | Hold | Downgraded | $85.00 | +56.9% | 03/04/2026 |
Last report
Sep 9, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$1.15 / $1.12
+2.67%beat
arrow_upward
Revenue / Est. (USD)
1.07B / 1.10B
-2.92%miss
arrow_downward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|
Revenue | 1.06B | 1.07B | 1.02B | 1.08B |
Cost of goods sold | 368.30M | 414.30M | 328.90M | 346.10M |
Cost of revenue | 368.30M | 414.30M | 328.90M | 346.10M |
Research and development expenses | 44.60M | 41.40M | 44.30M | 42.50M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 421.70M | 415.40M | 390.20M | 676.20M |
Operating expense | 516.30M | 506.60M | 482.40M | 766.40M |
Total operating expenses | 884.60M | 920.90M | 811.30M | 1.11B |
Operating income | 175.70M | 144.20M | 212.80M | -31.00M |
Other non operating income | 3.10M | -16.40M | 3.10M | 4.30M |
EBT including unusual items | 151.90M | 116.80M | 192.20M | -48.40M |
EBT excluding unusual items | 151.90M | 101.10M | 192.20M | -48.40M |
Income tax expense | 53.60M | 32.20M | 61.40M | 29.50M |
Effective tax rate | 35.29% | 27.57% | 31.95% | -60.95% |
Other operating expenses | - | - | - | - |
Net income | 98.30M | 84.60M | 130.80M | -77.90M |
Net profit margin | 9.27% | 7.94% | 12.77% | -7.20% |
Earnings per share | 1.10 | 1.15 | 1.10 | 1.21 |
Interest and investment income | - | - | - | - |
Interest expense | -25.40M | -24.40M | -22.40M | -20.90M |
Net interest expenses | -25.40M | -24.40M | -22.40M | -20.90M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 271.10M | 242.60M | 308.30M | 64.40M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1